Ascendis Pharma A (ASND) Tax Rate (2014 - 2026)
Ascendis Pharma A's (ASND) quarterly Tax Rate came in at 1406.31% in Q1 2026, up 140517.0% year-on-year from N/an in Q1 2025, and up 5376.94% quarter-over-quarter from 25.68% in Q4 2025.
Ascendis Pharma A (ASND) Tax Rate (2014 - 2026) Analysis & Trends
Ascendis Pharma A has disclosed Tax Rate across 13 years of filings, most recently posting 1406.31% for Q1 2026.
- Tax Rate for Q1 2026 came in at 1406.31%, up 140517.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 417.0% (up 41600.0% YoY), and the FY2025 annual result was 18.67%, up 1996.0% from the prior year.
- Tax Rate came in at 1406.31% for Q1 2026 at Ascendis Pharma A, up from 25.68% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1406.31% in Q1 2026 to a low of 1.95% in Q1 2024.
- The 5-year median for Tax Rate is 1.04% (2024), against an average of 85.96%.
- Across the five-year window, Tax Rate tumbled 424 bps in 2024 and jumped 140517 bps in 2026, its largest moves.
- Ascendis Pharma A's Tax Rate stood at 2.65% in 2022, then jumped by 170 bps to 7.14% in 2023, then tumbled by 59 bps to 2.9% in 2024, then soared by 785 bps to 25.68% in 2025, then jumped by 5377 bps to 1406.31% in 2026.
- The last three Tax Rate figures came in at 1406.31% (Q1 2026), 25.68% (Q4 2025), and 6.3% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ascendis Pharma A | 2.75 Bn | 2.08 Bn | 268.20 Mn | 1,406.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,406.31% |
| Mar 31, 2026 | 1,406.31% |
| Dec 31, 2025 | 25.68% |
| Dec 31, 2025 | 25.68% |
| Sep 30, 2025 | 6.30% |
| Sep 30, 2025 | 6.30% |
| Jun 30, 2025 | 10.99% |
| Jun 30, 2025 | 10.99% |
| Mar 31, 2025 | 1.13% |
| Mar 31, 2025 | 1.13% |
| Dec 31, 2024 | 2.90% |
| Dec 31, 2024 | 2.90% |
| Sep 30, 2024 | 1.04% |
| Sep 30, 2024 | 1.04% |
| Jun 30, 2024 | 0.21% |
| Jun 30, 2024 | 0.21% |
| Mar 31, 2024 | -1.95% |
| Mar 31, 2024 | -1.95% |
| Dec 31, 2023 | 7.14% |
| Dec 31, 2023 | 7.14% |